| Financial Year |
March 31 2023 |
| Monetary Funds |
448,361,395.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,107,217.25 |
| Accounts Receivable |
234,132,075.85 |
| Advances to Suppliers |
38,635,222.28 |
| Other Receivables |
3,511,783.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
79,970,333.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,856,806.91 |
| Total Current Assets |
814,446,966.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
15,941,204.16 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
13,777,273.84 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,671,961.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
979,569.34 |
| Deferred Income Tax Assets |
6,637,967.44 |
| Other Non-Current Assets |
27,008,910.04 |
| Sub-Total of Non-Current Assets |
66,867,972.79 |
| Total Assets |
881,314,939.33 |
| Short-Term Loans |
22,024,180.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
42,501,448.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,540,474.67 |
| Taxes Payable |
-1,747,971.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,637,031.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
815,524.17 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
69,770,687.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
239,852.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
315,447.36 |
| Total Liabilities |
70,086,135.06 |
| Paid-In Capital(Or Share Stock) |
79,999,999.00 |
| Capital Surplus |
564,268,363.24 |
| Surplus Reserve |
23,396,073.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
143,564,368.55 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
811,228,804.27 |
| Owner's Equity（Stockholder's Equity） |
811,228,804.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
881,314,939.33 |
